AgomAb Therapeutics N.V. American Depositary Shares (AGMB) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $554.0M, listed on NASDAQ, employing roughly 57 people, carrying a beta of 0.00 to the broader market. AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. Led by Tim Knotnerus, public since 2024-05-29.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for AGMB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →